Hsieh Lab on Twitter: "Very interesting work from the @AsanganiLab in Ewing Sarcoma linking it's pathognomonic fusion protein with LOXHD1." / Twitter
Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma: Molecular Therapy
Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy
Advances in immune checkpoint inhibitors for bone sarcoma therapy - ScienceDirect
Immunotherapy vs. Ewing Sarcoma: LET'S GO! — Little Warrior Foundation | Find the Cure for Childhood Cancer
Ewing sarcoma - Wikipedia
Precision Oncology in Sarcomas: Divide and Conquer | JCO Precision Oncology
Cellular immunotherapy strategies for Ewing sarcoma | Immunotherapy
Advances in immune checkpoint inhibitors for bone sarcoma therapy - ScienceDirect
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial - The Lancet Oncology
Ewing Sarcoma Treatment (PDQ®)–Patient Version - NCI
Sarcoma treatment in the era of molecular medicine | EMBO Molecular Medicine
Role of immunotherapy in Ewing sarcoma | Journal for ImmunoTherapy of Cancer
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology
Sarcoma treatment in the era of molecular medicine | EMBO Molecular Medicine
Role of immunotherapy in Ewing sarcoma | Journal for ImmunoTherapy of Cancer
Frontiers | Novel Immunotherapies for Osteosarcoma
Immunotherapy for sarcomas: new frontiers and unveiled opportunities | Journal for ImmunoTherapy of Cancer